Sponsor or institution
Clinical trials and research at Gan and Lee Pharmaceuticals, USA
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Gan and Lee Pharmaceuticals, USA that are recruiting, in Germany. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Comparing the potency of a new insulin (GZR33) with insulin degludec at steady state
This trial will test whether the new insulin GZR33 has similar blood-sugar–lowering strength to insulin degludec in adults with type 1 diabetes.
-
Insulin GZR4 versus insulin degludec for adults with type 2 diabetes
This trial will test whether a new long-acting insulin called GZR4 works as well as or better than approved long-acting insulins in adults with type 2 diabetes who are already taking basal insulin.
Quick answers
How many clinical trials run by Gan and Lee Pharmaceuticals, USA are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Germany. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.